The Severe Acute Respiratory Syndrome

New England Journal of Medicine

Volumn 349, Issue 25, 2003, Pages 2431-2441

  Peiris, Joseph S M ^a   Yuen, Kwok Y ^a   Osterhaus, Albert D M E ^b   Stöhr, Klaus ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; BETA INTERFERON; CORTICOSTEROID; GLYCYRRHIZIC ACID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; RECOMBINANT PROTEIN; VIRUS RNA;

ACUTE DISEASE; ARTIFICIAL VENTILATION; CANADA; CHILL; CHINA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORONAVIRUS; COUGHING; DISEASE TRANSMISSION; DYSPNEA; FEVER; HONG KONG; HUMAN; INTENSIVE CARE UNIT; LEUKOPENIA; MALAISE; MORTALITY; MYALGIA; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHINORRHEA; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SORE THROAT; THORAX RADIOGRAPHY; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION; VIRUS ISOLATION; VIRUS TRANSMISSION;

AGE FACTORS; ANIMALS; CONTACT TRACING; DISEASE OUTBREAKS; DISEASE RESERVOIRS; EPIDEMIOLOGY, MOLECULAR; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RISK FACTORS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 0346750858     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra032498     Document Type: Review

References (94)

1. Zhao Z, Zhang F, Xu M, et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol 2003;52:715-20.
2. Zhong NS, Zheng BJ, Li YM, et al. Epidemiological and aetiological studies of pacients with severe acute respiratory syndrome (SARS) from Guangdong in February 2003. Lancet 2003;362:1353-8.
3. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1986-94.
4. Global surveillance for severe acute respiratory syndrome. Wkly Epidemiol Rec 2003;78:100-9.
5. Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361: 1319-25.
6. KsiazekTG, Erdman D, Goldsmith C, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-66.
7. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-76.
8. Fouchier RAM, Kuiken T, Schutten M, et al. Koch's postulates fulfilled for SARS virus. Nature 2003;423:240.
9. Kuiken T, Fouchier RAM, Schutten M, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003;362:263-70.
10. World Health Organization Multicentre Collaborative Network for Severe Acute Respiratory Syndrome Diagnosis. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet 2003;361:1730-3.
11. Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003; 361:1767-72.
12. Chan KH, Poon LLM, Cheng VCC, et al. Detection of SARS coronavirus (SCoV) by RTPCR, culture, and serology in patients with acute respiratory syndrome (SARS). Emerg Infect Dis (in press).
13. Chan PKS, Tam JS, Lam CW, et al. Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1058-63.
14. Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003;348: 1995-2005.
15. Hong T, Wang JW, Sun YL, et al. Chlamydia-like and coronavirus-like agents found in dead cases of atypical pneumonia by electron microscopy. Zhonghua Yi Xue Za Zhi 2003;83:632-6. (In Chinese.)
16. Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300:1394-9.
17. Marra MA, Jones SJ, Astell CR, et al. The genome sequence of the SARS-associated coronavirus. Science 2003;300:1399-404.
18. Lim W, Government Virus Unit, Department of Health Hong Kong SAR, Presentation at the epidemiology breakout session, WHO Global Conference on Severe Acute Respiratory Syndrome, Kuala Lumpur, Malaysia, June 17-18, 2003.
19. Breiman RF, Evans MR, Priser W, et al. Role of China in the quest to define and control severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1037-41.
20. Guan Y, Zheng BJ, He YQ et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003;302:276-8.
21. Martina BE, Haagmans BL, Kuiken T, et al. SARS virus infection of cats and ferrets. Nature 2003;425:915.
22. Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003;361: 1761-6. [Erratum, Lancet 2003;361:1832.]
23. Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003;361: 1761-6. [Erratum, Lancet 2003;361:1832.]
24. Riley S, Fraser C, Donnelly CA, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 2003;300: 1961-6.
25. Lipsitch M, Cohen T, Cooper B, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 2003; 300:1966-70.
26. Dye C, Gay N. Modeling the SARS epidemic. Science 2003;300:1884-5.
27. Consensus document on the epidemiology of severe acute respiratory syndrome (SARS) WHO/CDS/CSR/GAR/2003.11. Geneva: World Health Organization, 2003. (Accessed November 20, 2003, at http://www. who.int/csr/sars/en/WHOconsensus.pdf.)
28. Varia M, Wilson S, Sarwal S, et al. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. CMAJ 2003;169:285-92.
29. Scales DC, Green K, Chan AK, et al. Illness in intensive care staff after brief exposure to severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1205-10.
30. Wu W, Wang J, Liu P, et al. A hospital outbreak of severe acute respiratory syndrome in Guangzhou, China. Chin Med J (Engl) 2003;116:811-8.
31. Chan PKS, Ip M, Ng KC, et al. Severe acute respiratory syndrome-associated coronavirus infection. Emerg Infect Dis (in press). (Also available at http://www.cdc.gov/ ncidod/EID/vol9no11/03-0421.htm.)
32. Lee HKK, Tso EYK, Chau TN, Tsang OTY, Choi KW, Lai TST. Asymptomatic severe acute respiratory syndrome-associated coronavirus infection. Emerg Infect Dis (in press). (Also available at http://www.cdc. gov/ncidod/EID/vol9no11/03-0401.htm.)
33. Biosafety and SARS incident in Singapore September 2003: report of the Review Panel on New SARS Case and Biosafety. September 2003. (Accessed November 20, 2003, at http://www.moh.gov.sg/sars/pdf/ Report_SARS_Biosafety.pdf.)
34. First data on stability and resistance of SARS coronavirus compiled by members of WHO laboratory network. Geneva: World Health Organization, 2003. (Accessed November 20, 2003, at http://www.who.int/csr/ sars/survival_2003_05_04/en/index.html.)
35. Outbreak of severe acute respiratory syndrome (SARS) at Amoy Gardens, Kowloon Bay, Hong Kong, main findings of the investigations. Hong Kong Special Administrative Region: Department of Health, April 2003. (Accessed November 20, 2003, at http:// www.info.gov.hk/info/ap/pdf/amoy_e.pdf.)
36. Tsou J. Architectural studies of air flow at Amoy Gardens, Kowloon Bay, Hong Kong, and its possible relevance to the spread of SARS status report. Hong Kong Special Administrative Region: Chinese University of Hong Kong, May 2003.
37. Ng SK. Possible role of an animal vector in the SARS outbreak at Amoy Gardens. Lancet 2003;362:570-2.
38. Hon KL, Leung CW, Cheng WT, et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 2003;361:1701-3.
39. Ho LC. SARS and pregnancy: experience in Hong Kong March-May 2003. Presented at the SARS Clinical Management Workshop, Hong Kong Special Administrative Region, June 13-14, 2003.
40. Update: outbreak of severe acute respiratory syndrome - worldwide, 2003. MMWR Morb Mortal Wkly Rep 2003;52: 241-8. [Erratum, MMWR Morb Mortal Wkly Rep 2003;52:284.]
41. Update: outbreak of severe acute respiratory syndrome - worldwide, 2003. MMWR Morb Mortal Wkly Rep 2003;52: 241-8. [Erratum, MMWR Morb Mortal Wkly Rep 2003;52:284.]
42. Hsu LY, Lee CC, Green JA, et al. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis 2003; 9:713-7.
43. Ruan Y, Wei CL, Ee LA, et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 2003;361:1779-85. [Erratum, Lancet 2003;361:1832.]
44. Ruan Y, Wei CL, Ee LA, et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 2003;361:1779-85. [Erratum, Lancet 2003;361:1832.]
45. Tsui SKW, Chim SSC, Lo YMD. Coronavirus genomic sequence variations and the epidemiology of the severe acute respiratory syndrome. N Engl J Med 2003;349:187-8.
46. Guan Y, Peiris JSM, Poon LLM, et al. Molecular epidemiology of SARS coronavirus in Hong Kong. Lancet (in press).
47. Mcgeer A. The Toronto outbreak. (Accessed November 20, 2003, at http://www. niaid.nih.gov/SARS/meetings/05_30_03/ PDF/mcgeer.pdf.)
48. Kumar D, Tellier R, Draker R, Levy G, Humar A. Severe acute respiratory syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant 2003;3:977-81.
49. Tsui PT, Kwok ML, Yuen H, Lai ST. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis 2003;9:1064-9.
50. Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348:1977-85.
51. Chan JW, Ng CK, Chan YH, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 2003; 58:686-9.
52. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003;289:2801-9. [Erratum, JAMA 2003;290:334.]
53. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003;289:2801-9. [Erratum, JAMA 2003;290:334.]
54. Avendano M, Derkach P, Swan S. Clinical course and management of SARS in health care workers in Toronto: a case series. CMAJ 2003;168:1649-60.
55. Rainer TH, Cameron PA, Smit D, et al. Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study. BMJ 2003;326:1354-8.
56. Wong KC, Leung KS, Hui M. Severe acute respiratory syndrome (SARS) in a geriatric patient with a hip fracture: a case report. J Bone Joint Surg Am 2003;85:1339-42.
57. Muller MP, Tomlinson G, Marrie T. Discriminative ability of laboratory parameters in severe acute respiratory syndrome (SARS). Presented at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, September 14-17, 2003. abstract.
58. Lu P, Zhou B, Chen X, et al. Chest X-ray imaging of patients with SARS. Chin Med J (Engl) 2003;116:972-5.
59. Zhao D, Ma D, Wang W, et al. Early X-ray and CT appearances of severe acute respiratory syndrome: an analysis of 28 cases. Chin Med J (Engl) 2003;116:823-6.
60. Wong KT, Antonio GE, Hui DS, et al. Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease. Radiology 2003;228: 395-400.
61. Idem. Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients. Radiology 2003; 228:401-6.
62. Antonio GE, Wong KT, Hui DS, et al. Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience. Radiology 2003;228:810-5.
63. Nicolaou S, Al-Nakshabandi NA, Muller NL. Radiologic manifestations of severe acute respiratory syndrome. N Engl J Med 2003; 348:2006.
64. Nicolaou S, Al-Nakshabandi NA, Muller NL. SARS: imaging of severe acute respiratory syndrome. AJR Am J Roentgenol 2003; 180:1247-9.
65. Muller NL, Ooi GC, Khong PL, Nicolaou S. Severe acute respiratory syndrome: radiographic and CT findings. AJR Am J Roentgenol 2003;181:3-8.
66. Grinblat L, Shulman H, Glickman A, Matukas L, Paul N. Severe acute respiratory syndrome: radiographic review of 40 probable cases in Toronto, Canada. Radiology 2003;228:802-9.
67. Antonio GE, Wong KT, Hui DS, et al. Imaging of severe acute respiratory syndrome in Hong Kong. AJR, Am J Roentgenol 2003; 181:11-7.
68. Lew TW, Kwek TK, Tai D, et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 2003;290:374-80.
69. Chan KS, Zheng JP, Mok YW, et al. Prognosis, outcome and sequelae of SARS. Respirology 2003;8:S36-S40.
70. Styra R, Gold W, Robinson S, et al. Posttraumatic stress disorder and quality of life in patients diagnosed with SARS. Presented at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, September 14-17, 2003. abstract.
71. Nicholls JM, Poon LL, Lee KC, etal. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003;361:1773-8.
72. Franks TJ, Chong PY, Chui P, et al. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol 2003;34:743-8.
73. Farcas GA, Mazzuli T, WiUey BM, et al. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus (SARS-CoV). Presented at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, September 14-17, 2003. abstract.
74. Nakajima N, Asahi-Ozaki Y, Nagata N, et al. SARS coronavirus-infected cells in lung detected by new in situ hybridization technique. Jpn J Infect Dis 2003;56:139-41.
75. WHO guidelines, Geneva: World Health Organization, 2003. (Accessed November 20, 2003, at htpp://www.who.int/csr/SARS/ en/index.html.)
76. Severe acute respiratory syndrome (SARS). Atlanta: Centers for Disease Control and Prevention, 2003. (Accessed November 20, 2003, at http://www.cdc.gov/ncidod/sars.)
77. Poon LLM, Chan KH, Wong OK, et al. Early diagnosis of SARS coronavirus infection by real time RT-PCR. J Clin Virol 2003; 28:233-8.
78. Wong RS, Wu A, To KF, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 2003;326:1358-62.
79. Chiu WK, Cheung PC, Ng KL, et al. Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong. Pediatr Crit Care Med 2003;4:279-83.
80. Tsou IY, Loh LE, Kaw GJ, Chan I, Chee TS. Severe acute respiratory syndrome (SARS) in a pediatric cluster in Singapore. Pediatr Radiol (in press).
81. So LK, Lau AC, Yam LY, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003;361:1615-7.
82. Cinat J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 2003;361:2045-6.
83. Idem. Treatment of SARS with human interferons. Lancet 2003;362:293-4. [Erratum, Lancet 2003;362:748.]
84. Idem. Treatment of SARS with human interferons. Lancet 2003;362:293-4. [Erratum, Lancet 2003;362:748.]
85. Loutfy MR. Blatt L, Ward S, et al. Preliminary results on the potential therapeutic benefit of interferon alfacon-1 plus steroids in severe acute respiratory syndrome. Presented at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, September 14-17, 2003. abstract.
86. Holmes KV, Enjuanes L. Virology: the SARS coronavirus: a postgenomic era. Science 2003;300:1377-8.
87. Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 2003;300:1763-7.
88. Ho JC, Ooi GC, Mok TY, et al. High dose pulse versus non-pulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med (in press).
89. Wong VW, Dai D, Wu AK, Sung JJ. Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J 2003;9:199-201.
90. Jia W, Gao W. Is traditional Chinese medicine useful in the treatment of SARS? Phytother Res 2003;17:840-1.
91. Singh K, Hsu L-Y, Villacian JS, Habib A, Fisher D, Tambyah PA. Severe acute respiratory syndrome: lessons from Singapore. Emerg Infect Dis (in press). (Also available at http://www.cdc.gov/ncidod/EID/vol9no10/ 03-0388.htm.)
92. Seto WH, Tsang D, Yung RWH, et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003;361:1519-20.
93. Yassi A, Noble MA, Daly P, Bryce E. Severe acute respiratory syndrome: guidelines were drawn up collaboratively to protect healthcare workers in British Columbia. BMJ 2003;326:1394-5.
94. Cluster of severe acute respiratory syndrome cases among protected health-care workers, Toronto, Canada, April 2003. MMWR Morb Mortal Wkly Rep 2003;52: 433-6.